PFIZER
About
At Pfizer, the Associate Data Scientist is responsible to assist Pfizer’s Data Management staff to leverage both internal and external data assets to deliver business insights, implement automation and Artificial Intelligence (AI) methods by collaborating with cross-functional teams within the organization with an overall goal of enhancing tactical and strategic decision making.
Updates & Highlights
Pfizer pulls out of summit with Germany's Merz over health care reform
Pfizer pulls out of summit with Germany's Merz over health care reform
Yahoo Finance · 23 minutes ago
Pfizer CEO warns German investment at risk over drug pricing policies
Pfizer CEO warns German investment at risk over drug pricing policies
Reuters · 42 minutes ago
Pfizer Stock 2026: CEO Lays Out the Case for a Growth Surge
Pfizer Stock 2026: CEO Lays Out the Case for a Growth Surge
TIKR.com · about 2 hours ago
Recent Openings
View all 5 jobsSr. Manager, AI Engineer
Θεσσαλονίκη, GRB, GR
AI Engineer III
Θεσσαλονίκη, GRB, GR
AI Engineer III (ΑΙ Innovation)
Θεσσαλονίκη, GRB, GR
Staff AI Engineer
Θεσσαλονίκη, GRB, GR
All Jobs
Sr. Manager, AI Engineer
Θεσσαλονίκη, GRB, GR
AI Engineer III
Θεσσαλονίκη, GRB, GR
AI Engineer III (ΑΙ Innovation)
Θεσσαλονίκη, GRB, GR
Staff AI Engineer
Θεσσαλονίκη, GRB, GR
Associate Data Scientist
Cambridge, MA, US
Culture & Mission
Benefits & Perks
Equity/Stock Options
Ownership in the company
Health Insurance
Medical, dental & vision
Remote Work
Work from anywhere flexibility
Learning Budget
Professional development
Generous PTO
Paid time off
Parental Leave
Family-friendly policies
401(k) Match
Retirement savings
Tech Stack
Core Values
Innovation
Pushing boundaries in AI/ML technology
Collaboration
Working together to achieve more
Excellence
Striving for the highest quality
Impact
Making a difference in the world
Office Locations
Team
Are you on the team at Pfizer?
Claim this company page to verify ownership, edit details, and respond to applicants.
Claim this company →News & Press
20 recentPfizer pulls out of summit with Germany's Merz over health care reform
Pfizer pulls out of summit with Germany's Merz over health care reform
Yahoo Finance · 23 minutes ago
Pfizer CEO warns German investment at risk over drug pricing policies
Pfizer CEO warns German investment at risk over drug pricing policies
Reuters · 42 minutes ago
Pfizer Stock 2026: CEO Lays Out the Case for a Growth Surge
Pfizer Stock 2026: CEO Lays Out the Case for a Growth Surge
TIKR.com · about 2 hours ago
Pfizer stock upgraded at RBC Capital Markets (PFE:NYSE)
Pfizer stock upgraded at RBC Capital Markets (PFE:NYSE)
Seeking Alpha · about 2 hours ago
Pfizer CEO warns German investment at risk over drug pricing policies
Pfizer CEO warns German investment at risk over drug pricing policies
Yahoo · about 4 hours ago
Prediction: Pfizer Stock Will Double on This Date
Prediction: Pfizer Stock Will Double on This Date
24/7 Wall St. · about 9 hours ago
Amneal and Pfizer GLP-1 Deal: New Growth Lever?
Amneal and Pfizer GLP-1 Deal: New Growth Lever?
Yahoo Finance · about 23 hours ago
Will obesity drugs save Pfizer from its post-COVID slump?
Will obesity drugs save Pfizer from its post-COVID slump?
Pharma Voice · 1 day ago
US FDA Approves Pfizer’s Hympavzi for Children with Hemophilia
US FDA Approves Pfizer’s Hympavzi for Children with Hemophilia
Новости GxP · 1 day ago
Pfizer’s Hympavzi secures FDA expanded indications for haemophilia
Pfizer’s Hympavzi secures FDA expanded indications for haemophilia
Pharmaceutical Technology · 1 day ago
GSK inks $10.6B Nuvalent buyout to challenge Roche and Pfizer in lung cancer
GSK inks $10.6B Nuvalent buyout to challenge Roche and Pfizer in lung cancer
Fierce Biotech · 1 day ago
Pfizer berobenatide side effects compare to Wegovy in Phase 2b trial
Pfizer berobenatide side effects compare to Wegovy in Phase 2b trial
qz.com · 1 day ago
US FDA approves Pfizer's bleeding disorder drug for children
US FDA approves Pfizer's bleeding disorder drug for children
Reuters · 1 day ago
Recon: FDA expands use of Pfizer’s Hympavzi for children with hemophilia; J&J to acquire Firefly Bio for $1B
Recon: FDA expands use of Pfizer’s Hympavzi for children with hemophilia; J&J to acquire Firefly Bio for $1B
RAPS.org · 2 days ago
Pfizer reports positive results from Phase IIb trial of berobenatide
Pfizer reports positive results from Phase IIb trial of berobenatide
Clinical Trials Arena · 2 days ago
ADA ‘26: Lilly’s dominance, Pfizer’s ‘foundational’ drug and Roche’s ‘me-too’ option
ADA ‘26: Lilly’s dominance, Pfizer’s ‘foundational’ drug and Roche’s ‘me-too’ option
BioPharma Dive · 2 days ago
Pfizer scores FDA pediatric expansion for hemophilia treatment Hympavzi
Pfizer scores FDA pediatric expansion for hemophilia treatment Hympavzi
Fierce Pharma · 2 days ago
Novo underwhelmed by drug it once fought Pfizer for
Novo underwhelmed by drug it once fought Pfizer for
statnews.com · 2 days ago
ADA: Metsera asset data support Pfizer’s ‘entry point’ into obesity market
ADA: Metsera asset data support Pfizer’s ‘entry point’ into obesity market
BioSpace · 2 days ago
Pharmalittle: We're reading about Lilly and Pfizer obesity drug data, Roche and J&J deals, and more
Pharmalittle: We're reading about Lilly and Pfizer obesity drug data, Roche and J&J deals, and more
statnews.com · 2 days ago